Fact CheckerSign in

NCT06715553Active, not recruiting

Interventional Programs' Impact on Patients' Quality of Life and Functioning

The Effect of Interventional Programs on Quality of Life and Functioning Among Patients With Schizophrenia

Source: ClinicalTrials.gov · Last updated 10 Mar 2025

Brief summary (registry, in English)

The objective of the study is to investigate the effect of interventional program in improving the quality of life for individuals with chronic schizophrenia The design of the study will be an interventional study - Randomized Control Trial - taking place in the Psychiatric hospital of the Cross Lebanon. Six types of intervention will be done on the patients such as ping-pong, sport exercise, psychoeducation program, nutrition, art therapy and bibliotherapy. A 100 patients adhering to the inclusion and exclusion criteria will be randomized into two groups (50 patients in the intervention group and 50 patients in the control group) - Simple Randomization. A Baseline and follow-up assessments will take place at the beginning of the study and after three months through using Arabic Validated Scales. The scales that be used are the following Positive and negative symptoms scale (PANSS), to determine severity of symptoms in patients. WHO quality of life questionnaire WHOQOL- BREF Arabic version: physical, psychological, social and environmental and EQ-5D scale, to determine quality of life of patients. MOCA scale to determine cognitive function, Rosenberg self-esteem questionnaire, Social functioning questionnaire QFS and Birchwood Insight Scale.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
86 (actual)
First submitted
13 Nov 2024
Start date
9 Aug 2024
Primary completion date
31 Dec 2025
Lead sponsor
Psychiatric Hospital of the Cross
NCT number
NCT06715553

What you commit to

  • Study type: Interventional
  • Participants enrolled: 86
  • From 9 Aug 2024 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe cognitive impairment

Other

  • Active substance use
  • Intellectual disability

Who the study is looking for

  • Individuals diagnosed with chronic schizophrenia according to DSM-V criteria
  • Aged 18-65.
  • Physically capable of participating in physical
  • Clinically stable

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Psychiatric Hospital of the Cross
Coordinator of this site? Confirm its status
BeirutLebanonUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.